Drugs / BIBH 1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02199886 | Jul 1998 → Dec 2001 | lung neoplasm | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02198274 | Feb → Oct 2000 | colorectal neoplasm | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBH 1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02199886 ↗ |
| Route | Intravenous | “Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer” NCT02198274 ↗ |